• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human POMK Polyclonal Antibody

The antibody against POMK was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-350 of human POMK (NP_115613.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-04991A

The antibody against POMK was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-350 of human POMK (NP_115613.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-04991A ClonalityPolyclonal
Host SpeciesRabbitTarget NamePOMK
Target SynonymsSGK196; MDDGA12; MDDGC12; POMKFormLiquid
Species ReactivityMouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesMouse kidney, Rat kidneyApplicationELISA, WB

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-350 of human POMK (NP_115613.1).Target SpeciesHuman
Uniprot IDQ9H5K3Immunogen Sequence
Background Information
  • Uniprot Id

    Q9H5K3

  • Target Species

    Human

  • Target Name

    POMK

  • Target Full Name

    Protein O-mannose kinase

  • Target Function

    Protein O-mannose kinase that specifically mediates phosphorylation at the 6-position of an O-mannose of the trisaccharide (N-acetylgalactosamine (GalNAc)-beta-1,3-N-acetylglucosamine (GlcNAc)-beta-1,4-mannose) to generate phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-1,3-N-acetylglucosamine-beta-1,4-(phosphate-6-)mannose). Phosphorylated O-mannosyl trisaccharide is a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity. Only shows kinase activity when the GalNAc-beta-3-GlcNAc-beta-terminus is linked to the 4-position of O-mannose, suggesting that this disaccharide serves as the substrate recognition motif.

  • Target Involvement

    Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A12 (MDDGA12); Muscular dystrophy-dystroglycanopathy limb-girdle C12 (MDDGC12)

  • Target Subcellular Location

    Endoplasmic reticulum membrane; Single-pass type II membrane protein.

  • Target Protein Families

    Protein kinase superfamily, Ser/Thr protein kinase family, STKL subfamily

  • Target Tissue Specificity

    Highest expression is observed in brain, skeletal muscle, kidney and heart in fetal and adult tissues.

  • Target Synonyms

    FLJ23356; MDDGA12; POMK; Probable inactive protein kinase-like protein SgK196; Protein kinase like protein SgK196; Protein kinase-like protein SgK196; Protein O-mannose kinase; SG196_HUMAN; SGK196; Sugen kinase 196

  • Target Background

    This gene encodes a protein that may be involved in the presentation of the laminin-binding O-linked carbohydrate chain of alpha-dystroglycan (a-DG), which forms transmembrane linkages between the extracellular matrix and the exoskeleton. Some pathogens use this O-linked carbohydrate unit for host entry. Loss of function compound heterozygous mutations in this gene were found in a human patient affected by the Walker-Warburg syndrome (WWS) phenotype. Mice lacking this gene contain misplaced neurons (heterotopia) in some regions of the brain, possibly from defects in neuronal migration. Alternative splicing of this gene results in multiple transcript variants.

Inquire Rabbit anti-Human POMK Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification